A new radioimmunoassay for the determination of the angiotensin-converting enzyme inhibitor Perindopril and its active metabolite in plasma and urine: Advantages of a lysine derivative as immunogen to improve the assay specificity
Authors:
- 31 December 1991
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 9 (7) , 517-524
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Radioimmunoassay of a New Angiotensin-Converting Enzyme Inhibitor (Perindopril) in Human Plasma and Urine: Advantages of Coupling Anion-Exchange Column Chromatography with RadioimmunoassayJournal of Pharmaceutical Sciences, 1990
- Pharmacokinetics of perindopril and its metabolites in healthy volunteersFundamental & Clinical Pharmacology, 1990
- Influence of food on the pharmacokinetics of perindopril and the time course of angiotensin-converting enzyme inhibition in serumClinical Pharmacology & Therapeutics, 1990
- Interspecies comparison of the metabolic pathways of perindopril, a new angiotensin-converting enzyme (ACE) inhibitorXenobiotica, 1990
- Gas chromatography—mass spectrometry of perindopril and its active free metabolite, an angiotensin convertase inhibitor: choice of derivatives and ionization modesJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patientsEuropean Journal of Clinical Pharmacology, 1987
- Inhibition of Angiotensin I-Converting Enzyme with S 9490Journal of Cardiovascular Pharmacology, 1984